111 related articles for article (PubMed ID: 11472263)
1. Physiochemical aspects of tubulin-interacting antimitotic drugs.
Correia JJ; Lobert S
Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
Panda D; Miller HP; Islam K; Wilson L
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
[TBL] [Abstract][Full Text] [Related]
3. A structural view of microtubule dynamics.
Nogales E
Cell Mol Life Sci; 1999 Oct; 56(1-2):133-42. PubMed ID: 11213253
[TBL] [Abstract][Full Text] [Related]
4. Tubulin-interactive natural products as anticancer agents.
Kingston DG
J Nat Prod; 2009 Mar; 72(3):507-15. PubMed ID: 19125622
[TBL] [Abstract][Full Text] [Related]
5. Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin's T5-loop.
Abel AC; Mühlethaler T; Dessin C; Schachtsiek T; Sammet B; Sharpe T; Steinmetz MO; Sewald N; Prota AE
J Biol Chem; 2024 May; 300(6):107363. PubMed ID: 38735475
[TBL] [Abstract][Full Text] [Related]
6. Understanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulations.
Natarajan K; Senapati S
PLoS One; 2012; 7(8):e42351. PubMed ID: 22879949
[TBL] [Abstract][Full Text] [Related]
7. The interaction of spongistatin 1 with tubulin.
Bai R; Smith AB; Pettit GR; Hamel E
Arch Biochem Biophys; 2022 Sep; 727():109296. PubMed ID: 35594923
[TBL] [Abstract][Full Text] [Related]
8. Beyond uniformity: Exploring the heterogeneous and dynamic nature of the microtubule lattice.
Romeiro Motta M; Biswas S; Schaedel L
Eur J Cell Biol; 2023 Dec; 102(4):151370. PubMed ID: 37922811
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity.
Williams NS; Burgett AW; Atkins AS; Wang X; Harran PG; McKnight SL
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2074-9. PubMed ID: 17287337
[TBL] [Abstract][Full Text] [Related]
10. Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel.
Bombuwala K; Kinstle T; Popik V; Uppal SO; Olesen JB; Viña J; Heckman CA
Beilstein J Org Chem; 2006 Jun; 2():13. PubMed ID: 16813651
[TBL] [Abstract][Full Text] [Related]
11. How do microtubule-targeted drugs work? An overview.
Jordan MA; Kamath K
Curr Cancer Drug Targets; 2007 Dec; 7(8):730-42. PubMed ID: 18220533
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
Jordan MA
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):1-17. PubMed ID: 12678749
[TBL] [Abstract][Full Text] [Related]
13. Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.
Krause W
Cancer Drug Resist; 2019; 2(1):82-106. PubMed ID: 35582143
[TBL] [Abstract][Full Text] [Related]
14. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.
Grohmann C; Walker F; Devlin M; Luo MX; Chüeh AC; Doherty J; Vaillant F; Ho GY; Wakefield MJ; Weeden CE; Kamili A; Murray J; Po'uha ST; Weinstock J; Kane SR; Faux MC; Broekhuizen E; Zheng Y; Shield-Artin K; Kershaw NJ; Tan CW; Witchard HM; Ebert G; Charman SA; Street I; Kavallaris M; Haber M; Fletcher JI; Asselin-Labat ML; Scott CL; Visvader JE; Lindeman GJ; Watson KG; Burgess AW; Lessene G
Cell Death Dis; 2021 Mar; 12(3):268. PubMed ID: 33712556
[TBL] [Abstract][Full Text] [Related]
15. Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy.
Forkosh E; Kenig A; Ilan Y
Pharmacol Res Perspect; 2020 Aug; 8(4):e00616. PubMed ID: 32608157
[TBL] [Abstract][Full Text] [Related]
16. Use of colchicine in cortical area 1 of the hippocampus impairs transmission of non-motivational information by the pyramidal cells.
Zaniani NR; Karami M; Porkhodadad S
Basic Clin Neurosci; 2013; 4(4):323-8. PubMed ID: 25337364
[TBL] [Abstract][Full Text] [Related]
17. Microtubule drugs: action, selectivity, and resistance across the kingdoms of life.
Dostál V; Libusová L
Protoplasma; 2014 Sep; 251(5):991-1005. PubMed ID: 24652407
[TBL] [Abstract][Full Text] [Related]
18. Vinca alkaloids.
Moudi M; Go R; Yien CY; Nazre M
Int J Prev Med; 2013 Nov; 4(11):1231-5. PubMed ID: 24404355
[TBL] [Abstract][Full Text] [Related]
19. Injection of colchicine intra-hippocampal cortical area 1 enhances novelty seeking behavior.
Karami M; Riahi N; Nadoushan MR
Indian J Pharmacol; 2013; 45(3):274-7. PubMed ID: 23833372
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?
Cucinotto I; Fiorillo L; Gualtieri S; Arbitrio M; Ciliberto D; Staropoli N; Grimaldi A; Luce A; Tassone P; Caraglia M; Tagliaferri P
J Drug Deliv; 2013; 2013():905091. PubMed ID: 23738077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
